Literature DB >> 8024751

Genetic basis of attenuation of the Sabin oral poliovirus vaccines.

P D Minor1, A J Macadam, D M Stone, J W Almond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8024751     DOI： 10.1006/biol.1993.1096

Source DB:  PubMed          Journal:  Biologicals        ISSN： 1045-1056            Impact factor:   1.856


× No keyword cloud information.
  23 in total

1.  Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.

Authors:  V Pliaka; Z Kyriakopoulou; D Tsakogiannis; I G A Ruether; C Gartzonika; S Levidiotou-Stefanou; A Krikelis; P Markoulatos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-05       Impact factor: 3.267

2.  Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina.

Authors:  Judith E Mueller; Maël Bessaud; Q Sue Huang; Laura C Martinez; Patricia A Barril; Viviane Morel; Jean Balanant; Judy Bocacao; Joanne Hewitt; Brad D Gessner; Francis Delpeyroux; Silvia V Nates
Journal:  Appl Environ Microbiol       Date:  2009-01-05       Impact factor: 4.792

3.  Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks.

Authors:  Stephanie B Troy; Leticia Ferreyra-Reyes; Chunhong Huang; Clea Sarnquist; Sergio Canizales-Quintero; Christine Nelson; Renata Báez-Saldaña; Marisa Holubar; Elizabeth Ferreira-Guerrero; Lourdes García-García; Yvonne A Maldonado
Journal:  J Infect Dis       Date:  2013-12-23       Impact factor: 5.226

4.  Real-time Polymerase Chain Reaction Analysis of Sewage Samples to Determine Oral Polio Vaccine Circulation Duration and Mutation After Mexican National Immunization Weeks.

Authors:  Stephanie B Troy; Leticia Ferreyra-Reyes; Sergio Canizales-Quintero; ChunHong Huang; Yu-Jin Lee; Renata Báez-Saldaña; Elizabeth Ferreira-Guerrero; Lourdes García-García; Yvonne Maldonado
Journal:  J Pediatric Infect Dis Soc       Date:  2012-06-29       Impact factor: 3.164

5.  A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.

Authors:  M Dan; J K Chantler
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Catching a virus in the act of RNA release: a novel poliovirus uncoating intermediate characterized by cryo-electron microscopy.

Authors:  Hazel C Levy; Mihnea Bostina; David J Filman; James M Hogle
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

7.  Use of a novel real-time PCR assay to detect oral polio vaccine shedding and reversion in stool and sewage samples after a mexican national immunization day.

Authors:  Stephanie B Troy; Leticia Ferreyra-Reyes; Chunhong Huang; Nadim Mahmud; Yu-Jin Lee; Sergio Canizales-Quintero; Harry Flaster; Renata Báez-Saldaña; Lourdes García-García; Yvonne Maldonado
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

8.  A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice.

Authors:  Elizabeth A Caine; Louise H Moncla; Monica D Ronderos; Thomas C Friedrich; Jorge E Osorio
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

9.  Recombinant oncolytic poliovirus eliminates glioma in vivo without genetic adaptation to a pathogenic phenotype.

Authors:  Elena Y Dobrikova; Trevor Broadt; Judith Poiley-Nelson; Xiaoyi Yang; Gopalan Soman; Steve Giardina; Ray Harris; Matthias Gromeier
Journal:  Mol Ther       Date:  2008-09-02       Impact factor: 11.454

Review 10.  Adjuvants and inactivated polio vaccine: a systematic review.

Authors:  Jennifer Hawken; Stephanie B Troy
Journal:  Vaccine       Date:  2012-10-03       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.